Active surveillance selection and 3-year durability in intermediate-risk prostate cancer following genomic testing.
Saved in:
| Title: | Active surveillance selection and 3-year durability in intermediate-risk prostate cancer following genomic testing. |
|---|---|
| Authors: | Lenz L; Myriad Genetics, Inc., Salt Lake City, UT, USA., Clegg W; Myriad Genetics, Inc., Salt Lake City, UT, USA., Iliev D; Myriad Genetics, Inc., Salt Lake City, UT, USA., Kasten CR; Myriad Genetics, Inc., Salt Lake City, UT, USA., Korman H; Comprehensive Urology, Royal Oak, MI, USA.; Wayne State University, Detroit, MI, USA., Morgan TM; University of Michigan, Ann Arbor, MI, USA., Hafron J; Michigan Institute of Urology, Troy, MI, USA., DeHaan A; Urologic Consultants, Wyoming, MI, USA., Olsson C; Integrated Medical Professionals, Melville, NY, USA., Tutrone RF Jr; Chesapeake Urology, Towson, MD, USA., Richardson T; Wichita Urology, Pratt, KS, USA., Cline K; Regional Urology, Shreveport, LA, USA., Yonover PM; UroPartners, Chicago, IL, USA., Jasper J; Myriad Genetics, Inc., Salt Lake City, UT, USA., Cohen T; Myriad Genetics, Inc., Salt Lake City, UT, USA., Finch R; Myriad Genetics, Inc., Salt Lake City, UT, USA., Slavin TP Jr; Myriad Genetics, Inc., Salt Lake City, UT, USA., Gutin A; Myriad Genetics, Inc., Salt Lake City, UT, USA. agutin@myriad.com. |
| Source: | Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2025 Jun; Vol. 28 (2), pp. 427-434. Date of Electronic Publication: 2024 Sep 05. |
| Publication Type: | Journal Article; Observational Study |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9815755 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5608 (Electronic) Linking ISSN: 13657852 NLM ISO Abbreviation: Prostate Cancer Prostatic Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
